drugset / Trial / NCT00660192
Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
RandomizedParallel-groupDouble-blindTreatment
Summary
The hypothesis of this study is that injection of botulinum toxin A into the muscles around the head (frontal, temporal, posterior neck, occipital) can reduce the intensity and frequency of migraine headaches by 50%.
Timeline
- Start
- 2008-01
- Primary completion
- 2012-07
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 200 iu | Intramuscular |
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 300 iu | Intramuscular |